| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_951917139791ec3a768eac3bb56ec280
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f87932bfccb68ebc36ee124c6d3964a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f322885e368eae5d74722bc28daf653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebaaf03a714aad5977b9914508974b4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75f8d6855f3b0bff4a76275ceba5d5ff |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N15-06 |
| filingDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d4d7d842f8d9ecfe898de1c3e13dd92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddf7e88abe04e9fe29cef38631e155ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd966e4627e29d51df16c084105364a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b67cebd773fcf0977bf4e57032affe |
| publicationDate |
2014-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014033806-A1 |
| titleOfInvention |
Methods of Formulating and Designing Liquid Drug Suspensions Containing Ion Exchange Resin Particles |
| abstract |
The invention relates to the formulation and quality control of liquid drug suspensions. In particular, the invention relates to methods of formulating liquid suspensions comprising drug-containing resin particles. The invention also relates to methods of confirming the acceptability of drug-containing resin particles for use in formulating liquid drug suspensions. The invention further relates to methods of formulating liquid suspensions in which drug-containing resin particles, the liquid suspension, or both are modified to achieve a desired in vitro dissolution profile. The invention also relates to a novel dissolution method and methods of predicting in vivo bioequivalence based on in vitro dissolution methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10086087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590228-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590081-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9198864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10933143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10668163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9549989-B2 |
| priorityDate |
2010-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |